Search Results 531-540 of 16963 for ozempic

  1. Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in NMIBC - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Pegfilgrastim-pbbk (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Pegfilgrastim-pbbk injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  3. A Study to Evaluate an Integrated Care Model Using Mobile Health Intervention in African American Patients with Hypertension - Mayo Clinic

    The purpose of this study is to learn about whether a community health clinic program on heart disease risk factors delivered through a digital app on ...

  4. A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease - Mayo Clinic

    About this study. This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data ...

  5. Dysfunction of Mesenchymal Stem/Stromal Cells Induced by Obesity - Mayo Clinic

    The purpose of this study is to determine how human obesity engages epigenetic mechanisms that impair human mesenchymal stem/stromal cells (MSC) mitochondrial ...

  6. Droxidopa (oral route) - Side effects & dosage - Mayo Clinic

    Droxidopa is used to treat neurogenic orthostatic hypotension (lightheadedness, dizziness, or fainting) caused by primary autonomic failure (eg, Parkinson's ...

  7. Ofatumumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Ofatumumab injection is also used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and ...

  8. An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of 2 daratumumab treatment regimens in participants with multiple myeloma who have received at ...

  9. Arimoclomol Prospective Study in Patients Diagnosed With NiemannPick Disease Type C - Mayo Clinic

    A prospective, randomised, double-blind, placebo controlled therapeutic study in patients with confirmed diagnosis of NiemannPick disease type C (NPC). The ...

  10. Cobicistat (oral route) - Side effects & dosage - Mayo Clinic

    Cobicistat is used to increase the effects of atazanavir or darunavir for the treatment of human immunodeficiency virus (HIV) infection. HIV is the virus that ...